Literature DB >> 18199641

Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway.

Christopher W Dawson1, Louise Laverick, Mhairi A Morris, Giorgos Tramoutanis, Lawrence S Young.   

Abstract

The Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) is an oncogenic protein which has previously been shown to engage the NF-kappaB, stress-activated MAP kinase, phosphatidylinositol 3-kinase (PI 3-kinase), and extracellular-regulated kinase (ERK)-MAPK pathways. In this study, we demonstrate that LMP1 activates ERK-MAPK in epithelial cells via the canonical Raf-MEK-ERK-MAPK pathway but in a Ras-independent manner. In agreement with the results of a previous study (B. A. Mainou, D. N. Everly, Jr., and N. Raab-Traub, J. Virol. 81:9680-9692, 2007), we show that the ability of LMP1 to activate ERK-MAPK mapped to its CTAR1 domain, the TRAF binding domain previously implicated in PI 3-kinase activation. A role for ERK-MAPK in LMP1-induced epithelial cell motility was identified, as LMP1-expressing cells displayed increased rates of haptotactic migration compared to those of LMP1-negative cells. These data implicate the ERK-MAPK pathway in LMP1-induced effects associated with transformation, suggesting that this pathway may contribute to the oncogenicity of LMP1 through its ability to promote cell motility and to enhance the invasive properties of epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199641      PMCID: PMC2268486          DOI: 10.1128/JVI.01888-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.

Authors:  A G Eliopoulos; M Stack; C W Dawson; K M Kaye; L Hodgkin; S Sihota; M Rowe; L S Young
Journal:  Oncogene       Date:  1997-06-19       Impact factor: 9.867

2.  Unique signaling properties of CTAR1 in LMP1-mediated transformation.

Authors:  Bernardo A Mainou; David N Everly; Nancy Raab-Traub
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

3.  Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).

Authors:  A G Eliopoulos; L S Young
Journal:  Oncogene       Date:  1998-04-02       Impact factor: 9.867

4.  Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation.

Authors:  M L Roberts; N R Cooper
Journal:  Virology       Date:  1998-01-05       Impact factor: 3.616

5.  Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.

Authors:  W E Miller; J L Cheshire; N Raab-Traub
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.

Authors:  O Gires; U Zimber-Strobl; R Gonnella; M Ueffing; G Marschall; R Zeidler; D Pich; W Hammerschmidt
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

7.  Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.

Authors:  A Kieser; E Kilger; O Gires; M Ueffing; W Kolch; W Hammerschmidt
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

8.  Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.

Authors:  E Kilger; A Kieser; M Baumann; W Hammerschmidt
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

9.  Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein.

Authors:  S J Leevers; C J Marshall
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

10.  Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins.

Authors:  P Lenormand; J M Brondello; A Brunet; J Pouysségur
Journal:  J Cell Biol       Date:  1998-08-10       Impact factor: 10.539

View more
  56 in total

1.  Modified Anoikis Assay That Functionally Segregates Epstein-Barr Virus LMP1 Strains into Two Groups.

Authors:  Laura R Wasil; Kathy H Y Shair
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

2.  Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.

Authors:  David N Everly; Bernardo A Mainou; Nancy Raab-Traub
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

3.  Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.

Authors:  Gretchen L Bentz; Christopher B Whitehurst; Joseph S Pagano
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

4.  Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.

Authors:  Laura R Wasil; Leizhen Wei; Christopher Chang; Li Lan; Kathy H Y Shair
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

5.  Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.

Authors:  Ru Jiang; Oleksandr Ekshyyan; Tara Moore-Medlin; Xiaohua Rong; Sean Nathan; Xin Gu; Fleurette Abreo; Eben L Rosenthal; Mingxia Shi; Joseph T Guidry; Rona S Scott; Lindsey M Hutt-Fletcher; Cherie-Ann O Nathan
Journal:  J Oral Pathol Med       Date:  2014-07-18       Impact factor: 4.253

6.  Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.

Authors:  Kai-Min Lin; Sue-Jane Lin; Juin-Han Lin; Pei-Yi Lin; Pu-Lin Teng; Hsueh-Erh Wu; Te-Huei Yeh; Ying-Piao Wang; Mei-Ru Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

7.  The interactome of EBV LMP1 evaluated by proximity-based BioID approach.

Authors:  Mark A Rider; Mujeeb R Cheerathodi; Stephanie N Hurwitz; Dingani Nkosi; Lauren A Howell; Deanna C Tremblay; Xia Liu; Fanxiu Zhu; David G Meckes
Journal:  Virology       Date:  2018-01-09       Impact factor: 3.616

Review 8.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

9.  Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.

Authors:  Maria Vaysberg; Olivia Hatton; Stacie L Lambert; Andrew L Snow; Bonnie Wong; Sheri M Krams; Olivia M Martinez
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

10.  Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma.

Authors:  Jing Chen; Chun-Fang Hu; Jing-Hui Hou; Qiong Shao; Li-Xu Yan; Xiao-Feng Zhu; Yi-Xin Zeng; Jian-Yong Shao
Journal:  J Transl Med       Date:  2010-03-26       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.